SPOTLIGHT: Bradley wins FDA OK


Bradley Pharmaceuticals has been notified by MediGene that MediGene received FDA approval to market Polyphenon E Ointment, 15 percent, a new drug indicated for the treatment of external genital and perianal warts. Report